Sun Pharmaceutical Industries Limited
SUNPHARMA · National Stock Exchange of India (NSE) · Pharmaceuticals
About the company
Sun Pharmaceutical Industries is India's largest pharmaceutical company and one of the largest generic drug manufacturers globally, with a major presence in the US, India, and emerging markets. The company produces specialty, generic, and over-the-counter medicines across a broad range of therapeutic categories. It completed a transformative acquisition of Ranbaxy Laboratories in 2015.
| Exchange | National Stock Exchange of India (NSE) |
| Ticker | SUNPHARMA |
| Sector | Pharmaceuticals |
| Indicative market cap USD | $47.00B |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
On its home market (National Stock Exchange of India (NSE)), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- National Stock Exchange of India — official exchange listing
Availability information only — not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in India
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only — not investment advice. Verify with the exchange, the company's filings and your broker.